+

WO2005003087A3 - Composes nouveaux utiles comme agents anti-bacteriens - Google Patents

Composes nouveaux utiles comme agents anti-bacteriens Download PDF

Info

Publication number
WO2005003087A3
WO2005003087A3 PCT/IB2004/002131 IB2004002131W WO2005003087A3 WO 2005003087 A3 WO2005003087 A3 WO 2005003087A3 IB 2004002131 W IB2004002131 W IB 2004002131W WO 2005003087 A3 WO2005003087 A3 WO 2005003087A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial agents
oxazole derivatives
derivatives
pharmaceutically acceptable
general formula
Prior art date
Application number
PCT/IB2004/002131
Other languages
English (en)
Other versions
WO2005003087A2 (fr
Inventor
Satya Surya Visweswara Akella
Kasinathanan Mathiyazhagan
Matte Mariana Samuel
Shakti Singh Solanki
Vijayan Magesh
Shiv Kumar Agarwal
Original Assignee
Orchid Chemicals & Pharm Ltd
Satya Surya Visweswara Akella
Kasinathanan Mathiyazhagan
Matte Mariana Samuel
Shakti Singh Solanki
Vijayan Magesh
Shiv Kumar Agarwal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharm Ltd, Satya Surya Visweswara Akella, Kasinathanan Mathiyazhagan, Matte Mariana Samuel, Shakti Singh Solanki, Vijayan Magesh, Shiv Kumar Agarwal filed Critical Orchid Chemicals & Pharm Ltd
Publication of WO2005003087A2 publication Critical patent/WO2005003087A2/fr
Publication of WO2005003087A3 publication Critical patent/WO2005003087A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés nouveaux de formule générale (I), leurs dérivés, leurs analogues, leurs formes tautomères, leurs stéréoisomères, leurs polymorphes, leurs hydrates, leurs solvates, leurs sels pharmaceutiquement acceptables et des compositions pharmaceutiquement acceptables qui les contiennent. L'invention concerne notamment des dérivés nouveaux d'oxazolidinone de formule générale (I).
PCT/IB2004/002131 2003-07-01 2004-06-28 Composes nouveaux utiles comme agents anti-bacteriens WO2005003087A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN539CH2003 2003-07-01
IN539/CHE/2003 2003-07-01

Publications (2)

Publication Number Publication Date
WO2005003087A2 WO2005003087A2 (fr) 2005-01-13
WO2005003087A3 true WO2005003087A3 (fr) 2005-03-17

Family

ID=33561911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/002131 WO2005003087A2 (fr) 2003-07-01 2004-06-28 Composes nouveaux utiles comme agents anti-bacteriens

Country Status (1)

Country Link
WO (1) WO2005003087A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
EP1713785A1 (fr) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Composes heterocycliques de biaryle halogenes et methodes de fabrication et d'utilisation
AU2005286731A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
CA2580857A1 (fr) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
CA2580762A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation comme agents therapeutiques
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006034440A2 (fr) * 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
WO2006034315A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et utilisation de ceux-ci comme agents therapeutiques
WO2007130075A1 (fr) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス，インコーポレイテッド トリアゾール類の合成方法
EP1902051A1 (fr) * 2005-06-09 2008-03-26 Merck Frosst Canada Ltd. Derives d'azacyclohexane comme inhibiteurs de la stearoyl-coenzyme a delta-9 desaturase
WO2008029266A1 (fr) * 2006-09-08 2008-03-13 Glenmark Pharmaceuticals S.A. Inhibiteurs de la stéaroyl coa désaturase
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
CN102224151A (zh) 2008-11-20 2011-10-19 万能药生物有限公司 新的抗微生物剂
EP2445887B1 (fr) 2009-06-26 2014-11-05 Panacea Biotec Limited Nouveaux azabicyclohexanes
WO2018170664A1 (fr) 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Composés d'oxazolidinone et leurs procédés d'utilisation en tant qu'agents antibactériens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021960A1 (fr) * 1998-10-09 2000-04-20 Astrazeneca Ab Heterocyclyl amino methyloxa zolidinones comme agents antibacteriens
WO2002006278A1 (fr) * 2000-07-17 2002-01-24 Ranbaxy Laboratories Limited Derives d'oxazolidinone utilises en tant qu'antimicrobiens
WO2004009587A1 (fr) * 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Derives de l'oxazolidinone, agents antibacteriens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021960A1 (fr) * 1998-10-09 2000-04-20 Astrazeneca Ab Heterocyclyl amino methyloxa zolidinones comme agents antibacteriens
WO2002006278A1 (fr) * 2000-07-17 2002-01-24 Ranbaxy Laboratories Limited Derives d'oxazolidinone utilises en tant qu'antimicrobiens
WO2004009587A1 (fr) * 2002-07-22 2004-01-29 Orchid Chemicals & Pharmaceuticals Ltd Derives de l'oxazolidinone, agents antibacteriens

Also Published As

Publication number Publication date
WO2005003087A2 (fr) 2005-01-13

Similar Documents

Publication Publication Date Title
WO2005003087A3 (fr) Composes nouveaux utiles comme agents anti-bacteriens
NO20054523L (no) Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika
IL192605A0 (en) 1,2-dihydropyridin-2-one derivatives and pharmaceutical compositions containing the same
WO2003084938A3 (fr) Nouveaux derives de pyrimidone
WO2003082205A3 (fr) Composes et procedes
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
WO2007148185A3 (fr) 3-amino-pyrrolidino-4-lactames substitués
WO2002051819A3 (fr) Composés hétérocycliques antibactériens, mode d'élaboration et compositions pharmaceutiques ainsi obtenues
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
UA94833C2 (en) Substituted bicyclolactams
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
AU6966498A (en) Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypol ipidaemic and antihypertensive properties
TW200510440A (en) Novel compounds
WO2003048116A3 (fr) Nouveaux composes et leur utilisation en medecine, leur procede de preparation et les compositions pharmaceutiques les contenant
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
WO2001090097A3 (fr) Nouveaux composes possedant une activite anti-inflammatoire, procede de preparation de ceux-ci et compositions pharmaceutiques les contenant
RS97004A (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
DE60336735D1 (de) Neue biologischaktive molekü le
AU2003223340A8 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2007014839A3 (fr) Inhibiteurs de la cathepsine k
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
WO2003093247A3 (fr) Nouveaux agents antibacteriens

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载